Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Molecular FormulaC32H30FN3O |
InChIKeyXYNOVGMRAYSMEO-UHFFFAOYSA-N |
CAS Registry2286231-31-8 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Discovery | IT | 22 Jul 2024 |